Company Search:
Advanced Search
Sponsored Links
Innovus Pharmaceuticals Inc Company Snapshot
Innovus Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Innovus Pharmaceuticals Inc with three other companies in this sector in the United States: Amicus Therapeutics, Inc (2016 sales of $4.96 million of which 100% was Biopharmaceutical), Aeglea Bio Therapeutics Inc ($4.63 million of which 100% was Pharmaceutical), and ArQule, Inc. ($4.71 million of which 100% was Chemical Compounds).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Innovus Pharmaceuticals Inc
  Stock Performance Chart for Innovus Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .11
(Figures in U.S. Dollars)
1 Week 26.4%   13 Weeks 29.4%  
4 Weeks 24.3%   52 Weeks -47.6%  
Innovus Pharmaceuticals Inc Key Data:
  Ticker: NORH Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,818,603
(Year Ending Jan 2017).
Employees: 1
  Currency: U.S. Dollars Market Cap: 18,087,750
  Fiscal Yr Ends: December Shares Outstanding: 164,434,088
  Share Type: Common Closely Held Shares: 10,082,739
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.